Establishment Labs Holdings (ESTA) Prices 2.286M Share Common Offering at $26.25/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Pre-Open Stock Movers 01/29: (LEE) (LB) (GE) Higher (BHVN) (EXTR) (XLNX) Lower (more...)
January 29, 2020 9:22 AM ESTToday's Pre-Open Stock Movers
Lee Enterprises, Incorporated (NYSE: LEE) 53% HIGHER; entered into a definitive agreement with Berkshire Hathaway to acquire BH Media Groups (BHMG) publications and The Buffalo News for $140 million in cash. Berkshire Hathaway is providing approximately $576 million in long-term financing to Lee at a 9% annual rate. The proceeds from the Berkshire financing will be used to pay for the acquisition, refinance Lees approximately $400 million of existing debt, and provide enough cash on Lees balance sheet to allow for the termination of Lees revolving credit facility.... More
After-Hours Stock Movers 01/28: (CNAT) (MTSI) (ARAY) Higher; (XLNX) (BHVN) (CHRW) Lower (more...)
January 28, 2020 5:32 PM ESTToday's After-Hours Stock Movers
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) 17.5% HIGHER; Conatus Pharmaceuticals and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today announced the companies have entered into a definitive agreement under which Histogen will merge with a wholly-owned subsidiary of Conatus in an all-stock transaction. The combined company will operate under the name Histogen, Inc., is expected to trade on the Nasdaq Capital Market under a new ticker symbol still to be determined and will focus on... More
Establishment Labs Holdings (ESTA) Announces Preliminary Results for Q4
January 28, 2020 4:52 PM ESTEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Womens Health initially in the breast aesthetics and reconstruction market today announced preliminary financial results for the fourth quarter and full year 2019, with total revenue growth for the quarter of 43% to 49%.
2019 was another extraordinary year for Establishment Labs, and we ended the year on a strong note with our sixth consecutive quarter of record revenue... More
Establishment Labs Holdings (ESTA) Announces Proposed $55M Share Common Offer
January 28, 2020 4:05 PM ESTEstablishment Labs Holdings Inc. (NASDAQ: ESTA) (the Company), a medical technology company focused on Womens Health initially in the breast aesthetics and reconstruction market today announced that it has commenced a public offering of approximately $55,000,000 of its common shares, to be sold by the Company in a registered public offering. The Company expects to... More
